Navigation Links
CIGNA HealthCare Continues Gains in Health Care Quality
Date:9/25/2007

CIGNA reports quality information again in 2007 to help create national

benchmarks for clinical quality among PPO plans

BLOOMFIELD, Conn., Sept. 25, 2007 /PRNewswire-FirstCall/ -- CIGNA HealthCare HMO and point-of-service (POS) plans have again achieved gains in key measures of health care quality that resulted in more members receiving important preventive care and chronic care services, according to data released today by the National Committee for Quality Assurance (NCQA). NCQA's annual report includes information on dozens of measures of health care quality.

For the second consecutive year, CIGNA HealthCare also provided NCQA with information on quality indicators for PPO and consumer-driven health care plans, this year encompassing 39 markets and approximately 4.3 million members. CIGNA HealthCare was the first national health plan to voluntarily commit to providing this information to NCQA, which is using the data to help establish national quality benchmarks for PPO plans.

"We have participated in NCQA's measurement and reporting on health care quality for many years and are pleased by our results this year and our record of improvement over time," said Dr. Jeffrey Kang, chief medical officer for CIGNA HealthCare. "We continue to enhance our health advocacy programs, analytics and information tools to drive these ongoing improvements, and we are pleased to extend our efforts to reach even more of our members than ever before."

For the sixth consecutive year, an internal analysis of CIGNA HealthCare's scores shows their combined national averages to be higher than both the Quality Compass(R) national average, and the average of its main competitors, for the majority of preventive and chronic care measures used by NCQA in accrediting health care plans. The national average of scores reported by CIGNA HealthCare plans in Quality Compass(R) across the "effectiveness of care" and "access/availability of care" measures
'/>"/>

SOURCE CIGNA HealthCare
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. CIGNA HealthCare Teams With HopeLab to Help Blast Teen Cancer
2. Healthcare sector is now a multi billion-dollar industry in India
3. Iodex goes to SmithKline Beecham consumer Healthcare
4. Healthcare Professionals Might Want To Rethink Their Dress Code
5. WHO report asks for improved healthcare for mother and child
6. New X-ray machine launched by GE Healthcare
7. India To March Ahead in The Global HealthCare Competition
8. Medical Fraternity Urged To Revamp Indian Healthcare
9. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
10. Need For Social Churning Emphasized In CMC Meet On ‘Leadership In Healthcare
11. LINK Applied Genomics Programme Promises To Revolutionize Healthcare Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... July 23 /PRNewswire-FirstCall/ - Cardiome Pharma ... it has entered into an,agreement with CR Intrinsi...CR Intrinsic Investors, LLC, an affiliate of S.A.C...rtible preferred shares for gross proceeds of,US$2...for general corporate,purposes, costs associated w...
(Date:7/23/2008)...DNA to create faster, smaller, and more powerful c...scrambling to develop successful ways to use genet...professor at Rensselaer Polytechnic Institute sugg...tations, all we have to do is literally look aroun...rk Changizi has begun to develop a technique to tu...
(Date:7/23/2008)...-USNewswire/ -- The Children,s,Hospital of Philade...ion,gift that will enable the opening of a new ped...is gift, made possible by Athena and Nicholas,Kara... in the history of,Children,s Hospital and will gi...communities convenient access to world-class pedia...
(Date:7/23/2008)... Times may be tough, but,Hollywood,s young stars l...a dazzling new smile to boost confidence. Cosmetic...ty clients beam in on success, citing his,experien...confidence they,need for stardom. In agreement is ...ge smile designed by Dr. Kosdon., MTV,s Rock The ...
Breaking Medicine News(10 mins):Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:Study suggests human visual system could make powerful computer 2Health News:Study suggests human visual system could make powerful computer 3Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 2Health News:$15 Million Donation From The Karabots Foundation Enables The Children's Hospital of Philadelphia to Open a New Pediatric Care Facility in Norristown, Pennsylvania 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2
...ueen Kate Moss has confided to Sir Richard Branso... the media about her cocaine addiction. // Richar...te Moss is very close to him and he has known her ...reer in 1999. She said to him that it made her fac...
...elbourne and La Trobe University have identified t...ins such as wheat and barley. With the stress bein...rchers fell that this discovery would allow them t... The genes are important in the production of bet...
... soon go on Phase I trial. It maybe as early as a ...ar Shaw. Ms.Shaw was speaking at the conference ...oundation(MDRF) on awards for innovation and R&D./...ics in India and any research related to diabetes ...
...e-changing operation in India and returned home sa...vice (NHS), for being// overweight. David Rogers,...he NHS that he was too overweight for the double h...tely needed. Weighing almost 140 kg, he was told t...
Other Medicine News:Health News:Overweight Briton Underwent Successful Surgery In India Being Denied By NHS 2
(Date:7/22/2008)...y 22 /- Following a,thoroug...of Progen,Pharmaceuticals Limited (ASX: PGL; Nasda...the PI-88 phase 3 study in liver cancer. Progen co...sting portfolio of compounds and,the company will ...opportunities through Merger & Acquisition activit...
(Date:7/22/2008)...s Development Plan Completed Successfully, DUBLIN...n Corporation,plc (NASDAQ: AMRN ) today announced...he U.S. Food and Drug Administration (FDA) to disc...treatment of,hypertriglyceridemia. Following these... with AMR101 in hypertriglyceridemia., Dr. Declan...
(Date:7/22/2008)...tress the Importance to Patients of Passing a ... RICHMOND, Va., July 22 /-...ow-on biologics and biopharmaceuticals, today,anno...ill present at a,Congressional briefing on Friday,...or establishing an approval pathway for follow-on,...
(Date:7/22/2008)...ve Laser Lipolysis Technology in the European ...., July 22 /- Cynosure, Inc...cturer of a broad array of,light-based aesthetic t...k,for Smartlipo MPX(TM), the company,s high-powere...y fat and tighten skin through collagen,remodeling...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 2Cynosure Receives CE Mark for Smartlipo MPX(TM) Workstation 3Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 1Immunotec Inc announces appointment of President 26 CEO James A Northrop 1219 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 1PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 2PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 3PTC Therapeutics Announces Pharmacokinetic and Safety Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy 500 4 242 7 million awarded for metastatic colon cancer research 771 1 242 7 million awarded for metastatic colon cancer research 771 2 242 7 million awarded for metastatic colon cancer research 771 3Nanoparticle exposures happen says expert 769 1Nanoparticle exposures happen says expert 769 2
...nship Between Ability to Function and Treatment of...DIANAPOLIS, May 21, 2007 /PRNewswire-FirstCall/ --...ty disorder (GAD),treated with Cymbalta(R) (duloxe...everyday activities at home, work and in social,si...s in global,functioning were the result of improve...
...TER, MN, May 21, 2007-- Serotonin is a,neurotransm...yo,Clinic researchers set out to determine the rol... The study involved 48 females --,including indivi...duals with both IBS and dyspepsia, and healthy vol...nd intestines of each,patient and serotonin levels...
Other Medicine Technology:Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 2Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 3Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 4Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 5Data Suggest Cymbalta Improved Functioning in Patients with,Generalized Anxiety Disorder 6
Basic-level interpretive resting ECG
XALATAN is a prescription medicine used to lower eye pressure, also called intraocular pressure, or IOP, in patients with ocular hypertension (abnormally high IOP) or open-angle glaucoma.
The ECG-9010 meets IEC60601-2-51 new international standard for digital electrocardiographs specifying accuracy and digital filter performance. ECG data can be reviewed and managed on a Windows PC wi
The UltraVac V1 allows for unprecedented chamber stability and high vacuum levels with venturi systems. Vacuum and flow are proportionately linked on a venturi pump and cannot be independently adjust
Medicine Products: